相关实验视频
Updated: Jul 7, 2026

06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
二手烟与影响囊性纤维化肺部疾病的基因之间的相互作用
J Michael Collaco1, Lori Vanscoy, Lindsay Bremer
1Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
JAMA
|January 31, 2008
概括
对二手烟的暴露显著恶化了囊性纤维化 (CF) 患者的肺功能. 包括CFTR和TGFbeta1在内的特定基因变异放大了这些有害影响,强调了避免CF患者暴露于烟雾的重要性.
科学领域:
- 肺部医学 肺部医学
- 遗传学 是一个遗传学.
- 环境健康 环境健康
背景情况:
- 囊性纤维化 (CF) 呈现出显著的疾病变异,尽管单基因病因.
- 研究基因环境相互作用对于理解疾病异质性至关重要.
研究的目的:
- 评估二手烟 (SHS) 暴露与CF患者肺功能之间的关联.
- 确定社会经济地位 (SES) 是否影响SHS与肺病的关系.
- 为了确定影响SHS对CF肺功能的影响的基因环境相互作用.
主要方法:
- 来自美国囊性纤维化双胞胎和兄弟姐妹研究以及CF基金会数据注册表的肺功能数据的回顾性分析.
- 根据环境 (SHS暴露) 和遗传因素进行分层.
- 评估横截面和纵向肺功能指标.
主要成果:
- 二手烟暴露与CF患者的横截面和纵向肺功能显著下降有关.
- 社会经济地位并没有影响SHS对肺功能的不良影响.
- CFTR和TGFbeta1中的基因变异放大了SHS对肺功能的负面影响.
结论:
- 任何程度的二手烟暴露都会对患有囊性纤维化的人的肺功能产生不利影响.
- CFTR和TGFbeta1基因的遗传变异加剧了SHS暴露对肺功能的有害影响.
相关概念视频
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...

